# The Safety and Effectiveness of Megace in HIV-Infected Women

> **NCT00002345** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 40 (—)

## Conditions studied

- Anorexia
- Cachexia
- HIV Infections

## Interventions

- **DRUG:** Megestrol acetate

## Key facts

- **NCT ID:** NCT00002345
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2007-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002345, "The Safety and Effectiveness of Megace in HIV-Infected Women". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00002345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*